The Cultivation Modality and Barrier Maturity Modulate the Toxicity of Industrial Zinc Oxide and Titanium Dioxide Nanoparticles on Nasal, Buccal, Bronchial, and Alveolar Mucosa Cell-Derived Barrier Models
Authors:
- Helene StuetzHSHelene Stuetz
- Eva Ingeborg ReihsEREva Ingeborg Reihs
- Winfried NeuhausWinfried Neuhaus
- Maren PfluegerMPMaren Pflueger
- Harald HundsbergerHHHarald Hundsberger
- Peter ErtlPEPeter Ertl
- Christian ReschCRChristian Resch
- Gerald BauerGBGerald Bauer
- Günter PovodenGPGünter Povoden
- Mario RothbauerMRMario Rothbauer
Preprint
- 25 January 2023
- preprint
- Published by MDPI AG in Preprints.org
Abstract
As common industrial by-products, airborne engineered nanomaterials are considered important environmental toxicants to monitor due to their potential health risks to humans and animals. The main uptake routes of airborne nanoparticles are nasal and/or oral inhalation, which are known to enable the transfer of nanomaterials into the blood stream resulting in rapid distribution in the body. Consequently, mucosal barriers present in nose, buccal and lung have been identified and intensively studied as the key tissue barrier to nanoparticle translocation. Despite decades of research, surprisingly little is known about the differences among various mucosa tissue types to tolerate nanoparticle exposures. One limitation in comparing nanotoxicological data sets can be linked to a lack of harmonization and standardization of cell-based assays, where a) different cultivation conditions such as air-liquid interface or submerged cultures, b) varying barrier maturity and c) diverse media substitutes have been used. The current comparative nanotoxicological study therefore aims at analyzing the toxic effects of nanomaterials on four human mucosa barrier models including nasal (RPMI2650), buccal (TR146), alveolar (A549), and bronchial (Calu-3) mucosal cell lines to better understand the modulating effects of tissue maturity, cultivation conditions and tissue type using standard Transwell cultivations at liquid-liquid and air-liquid interfaces. Overall, cell size, confluency, tight junction localization, and cell viability as well as barrier formation using 50% and 100% confluency was monitored using trans-epithelial-electrical resistance (TEER) measurements and Presto Blue assays of immature (e.g. 5 days) and mature (e.g. 22 days) cultures in the presence and absence of corticosteroids such as hydrocortisone. Results of our study show that cellular responses to increasing nanoparticle exposures are highly cell type specific, where bronchial mucosal cell barriers models cultivated under ALI conditions showed less tolerance to acute ZnO nanoparticle exposures. Additionally, stronger toxicities are found using early mucosa barriers compared to later barrier models being maturated under air-liquid cultivation conditions.Keywords
All Related Versions
This publication has 36 references indexed in Scilit:
- Toxicity of ZnO nanoparticles (NPs) to A549 cells and A549 epithelium in vitro: Interactions with dipalmitoyl phosphatidylcholine (DPPC)Environmental Toxicology and Pharmacology, 2017
- Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal productsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2016
- Functional and cytometric examination of different human lung epithelial cell types as drug transport barriersArchives of Pharmacal Research, 2016
- Morphological impact of zinc oxide particles on the antibacterial activity and human epithelia toxicityMaterials Science and Engineering: C, 2015
- The Characterization of the Human Nasal Epithelial Cell Line RPMI 2650 Under Different Culture Conditions and Their Optimization for an Appropriate in vitro Nasal ModelPharmaceutical Research, 2014
- A microdevice for parallelized pulmonary permeability studiesBiomedical Microdevices, 2013
- Cytotoxicity of zinc oxide (ZnO) nanoparticles is influenced by cell density and culture formatArchives of Toxicology, 2010
- RPMI 2650 epithelial model and three-dimensional reconstructed human nasal mucosa as in vitro models for nasal permeation studiesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2010
- Metabolism and bioactivation of toxicants in the lung. The in vitro cellular approachExperimental and Toxicologic Pathology, 2005
- In vitro versus in vivo exposure to combustion emissionsExperimental and Toxicologic Pathology, 2005